(Q40821931)

24 September 2017

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease (English)

1 reference

24 September 2017

0 references

Levy ML

1

1 reference

24 September 2017

Cummings JL

2

1 reference

24 September 2017

Fairbanks LA

3

1 reference

24 September 2017

Sultzer DL

4

1 reference

24 September 2017

Small GW

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

24 September 2017

Biological Psychiatry

1 reference

24 September 2017

45

1 reference

24 September 2017

4

1 reference

24 September 2017

422-425

1 reference

Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Limbic lobe involvement in presenile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900041-9

10.1016/S0006-3223(98)00041-9

7 January 2021

Identifiers

DOI

1 reference

release_hjb5lhcd6jcr5crup72qnu2byi

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hjb5lhcd6jcr5crup72qnu2byi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference